Please login to the form below

Not currently logged in
Email:
Password:

Celgene promotes senior EMEA figures

Marie-France Tschudin and Stefano Portolano take on new roles
Marie France Tschudin

Celgene has promoted two senior EMEA figures, handing Marie-France Tschudin and Stefano Portolano new roles.

Tschudin becomes corporate vice president for Celgene's Haematology/Oncology franchise and will report directly to Tuomo Pätsi, president of EMEA.

The role gives her P&L responsibility for all EMEA markets, and sees her manage functions dedicated to developing and supporting the franchise.

Tschudin has held a number of leadership positions since joining the company in 2006, including several country and regional management roles across Europe.

She has 20 years of experience in sales, marketing and general management roles in the pharmaceutical industry, focusing on oncology and haematology.

Stefano Portolano

Meanwhile, Celgene has promoted Stefano Portolano to vice president of strategy and commercial operations.
 
The newly-created role includes the coordination of novel initiatives, the creation of value-added services and digital channels.

Portolano will also manage Celgene's commercial operations functions across the EMEA region, which include training, sales and marketing effectiveness, and congress management.

Prior to this appointment Portolano was vice president - marketing haematology at Celgene EMEA with responsibility for the strategic development and positioning of Celgene's brands and before that he served as general manager for Celgene Italy.

5th January 2015

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Pandemic preparedness
The pandemic preparedness paradox
Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...

Infographics